These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 2880858)

  • 1. On-line low-level radiometric detection of [14C]remoxipride in liquid chromatographic effluents. Application to urine samples.
    Veltkamp AC; Das HA; Frei RW; Brinkman UA
    J Chromatogr; 1987 Jan; 384():357-69. PubMed ID: 2880858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of remoxipride in plasma and urine by reversed-phase column liquid chromatography.
    Nilsson LB
    J Chromatogr; 1990 Mar; 526(1):139-50. PubMed ID: 1971278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On-line radiometric determination of [14C]-urapidil and its main metabolises in rat plasma, using post-column ion-pair extraction and solvent segmentation techniques.
    Veltkamp AC; Das HA; Frei RW; Brinkman UA
    J Pharm Biomed Anal; 1988; 6(6-8):609-22. PubMed ID: 16867326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of remoxipride in human plasma and urine by reversed-phase ion-pair high-performance liquid chromatography.
    Chiou RH; Lo MW
    J Chromatogr; 1992 Oct; 581(2):300-5. PubMed ID: 1452624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid chromatographic studies on the aqueous solution conformation of substituted benzamides related to remoxipride.
    Clark CR; Smith FT; Clark MR; Garcia-Roura LE
    J Chromatogr Sci; 1990 Mar; 28(3):93-6. PubMed ID: 1980276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of 5-substituted 5-hydroxy-2-pyrrolidones, metabolites of the antipsychotic benzamide remoxipride.
    Gawell L; Hagberg CE; Högberg T; Widman M
    Acta Chem Scand (Cph); 1989 May; 43(5):476-80. PubMed ID: 2577294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of a peak compression system for a remoxipride metabolite (FLA797) and its application to bioanalysis.
    Nilsson LB
    J Chromatogr; 1992 Feb; 591(1-2):207-17. PubMed ID: 1613054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition of remoxipride in different species. Species differences in metabolism.
    Widman M; Nilsson LB; Bryske B; Lundström J
    Arzneimittelforschung; 1993 Mar; 43(3):287-97. PubMed ID: 8489555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversed-phase high-performance liquid chromatographic separation of 14C-labelled toloxatone and its metabolites.
    Vajta S; Le Moing JP; Rovei V
    J Chromatogr; 1984 Nov; 311(2):329-37. PubMed ID: 6520180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans.
    Prakash C; Kamel A; Gummerus J; Wilner K
    Drug Metab Dispos; 1997 Jul; 25(7):863-72. PubMed ID: 9224781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High sensitivity determination of the remoxipride hydroquinone metabolite NCQ-344 in plasma by coupled column reversed-phase liquid chromatography and electrochemical detection.
    Nilsson LB
    Biomed Chromatogr; 1998; 12(2):65-8. PubMed ID: 9568272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radio high-performance liquid chromatographic determination of 14C-labelled LF 2-0254, A 1,4-dihydropyridine calcium antagonist, in rat and dog plasma using off-line liquid scintillation counting.
    Baillet G; Pourcelot A; Weil A; Prevost C; Guichard JP
    J Chromatogr; 1988 Dec; 456(1):183-90. PubMed ID: 3243866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bimodal column switching liquid chromatographic assay of six metabolites of [14C] felodipine in rat urine.
    Weidolf L
    J Chromatogr; 1985 Sep; 343(1):85-97. PubMed ID: 4066864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-performance liquid chromatographic method for the radiometric determination of [14C] bucromarone in human plasma utilizing non-radiolabeled bucromarone as an internal standard.
    Everett DW; Foley JE; Singhvi SM; Weinstein SH; Warrington SJ
    J Chromatogr; 1989 Feb; 487(2):365-73. PubMed ID: 2723003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Online solid phase extraction with liquid chromatography-tandem mass spectrometry to analyze remoxipride in small plasma-, brain homogenate-, and brain microdialysate samples.
    Stevens J; van den Berg DJ; de Ridder S; Niederländer HA; van der Graaf PH; Danhof M; de Lange EC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Apr; 878(13-14):969-75. PubMed ID: 20303836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remoxipride: pharmacokinetics and effect on plasma prolactin.
    Movin-Osswald G; Hammarlund-Udenaes M
    Br J Clin Pharmacol; 1991 Sep; 32(3):355-60. PubMed ID: 1685665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability indicating LC method for the determination of pipamperone.
    Trabelsi H; Hassen IE; Bouabdallah S; Bouzouita K; Safta F
    J Pharm Biomed Anal; 2005 Oct; 39(5):914-9. PubMed ID: 16040223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding characteristics of remoxipride and its metabolites to dopamine D2 and D3 receptors.
    Mohell N; Sällemark M; Rosqvist S; Malmberg A; Högberg T; Jackson DM
    Eur J Pharmacol; 1993 Jul; 238(1):121-5. PubMed ID: 8405075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subchronic treatment of rats with remoxipride fails to modify sigma binding sites in the brain.
    Ericson H; Ross SB
    Eur J Pharmacol; 1992 Jun; 226(2):157-61. PubMed ID: 1353452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo effects of remoxipride and aromatic ring metabolites in the rat.
    Ahlenius S; Ericson E; Hillegaart V; Nilsson LB; Salmi P; Wijkström A
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1356-66. PubMed ID: 9400011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.